|
1.
|
Seim I, Collet C, Herington AC and Chopin
LK: Revised genomic structure of the human ghrelin gene and
identification of novel exons, alternative splice variants and
natural antisense transcripts. BMC Genomics. 8:2982007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Kojima M and Kangawa K: Structure and
function of ghrelin. Results Probl Cell Differ. 46:89–115. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Kojima M and Kangawa K: Ghrelin: Structure
and function. Physiol Rev. 85:495–522. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Hubacek JA, Bloudícková S, Bohuslavová R,
Táborský P, Polakovic V, Sazamová M, Svítilová E, Vlasák J, Sojková
I, Ryba M, et al: Ghrelin variants influence development of body
mass index and plasma levels of total cholesterol in dialyzed
patients. Clin Chem Lab Med. 45:1121–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ruperto M, Sánchez-Muniz FJ and Barril G:
A clinical approach to the nutritional care process in
protein-energy wasting hemodialysis patients. Nutr Hosp.
29:735–750. 2014.(In Spanish). PubMed/NCBI
|
|
6.
|
Nagaya N, Kojima M, Uematsu M, Yamagishi
M, Hosoda H, Oya H, Hayashi Y and Kangawa K: Hemodynamic and
hormonal effects of human ghrelin in healthy volunteers. Am J
Physiol Regul Integr Comp Physiol. 280:R1483–R1487. 2001.PubMed/NCBI
|
|
7.
|
Caliskan Y, Gorgulu N, Yelken B, Yazici H,
Oflaz H, Elitok A, Turkmen A, Bozfakioglu S and Sever MS: Plasma
ghrelin levels are associated with coronary microvascular and
endothelial dysfunction in peritoneal dialysis patients. Ren Fail.
31:807–813. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Pérez-Fontán M, Cordido F,
Rodríguez-Carmona A, Peteiro J, García-Naveiro R and García-Buela
J: Plasma ghrelin levels in patients undergoing haemodialysis and
peritoneal dialysis. Nephrol Dial Transplant. 19:2095–2100. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Tentolouris N, Makrilakis K, Doulgerakis
D, Moyssakis I, Kokkinos A, Kyriaki D, Georgoulias C, Stathakis C
and Katsilambros N: Increased plasma ghrelin levels in chronic
renal failure are not associated with hemodynamic parameters. Horm
Metab Res. 37:646–652. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Yoshimoto A, Mori K, Sugawara A, Mukoyama
M, Yahata K, Suganami T, Takaya K, Hosoda H, Kojima M, Kangawa K,
et al: Plasma ghrelin and desacyl ghrelin concentrations in renal
failure. J Am Soc Nephrol. 13:2748–2752. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Mori K, Yoshimoto A, Takaya K, Hosoda K,
Ariyasu H, Yahata K, Mukoyama M, Sugawara A, Hosoda H, Kojima M, et
al: Kidney produces a novel acylated peptide, ghrelin. FEBS Lett.
486:213–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Barazzoni R, Zanetti M, Biolo G and
Guarnieri G: Metabolic effects of ghrelin and its potential
implications in uremia. J Ren Nutr. 15:111–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Barazzoni R, Zanetti M, Stulle M, Mucci
MP, Pirulli A, Dore F, Panzetta G, Vasile A, Biolo G and Guarnieri
G: Higher total ghrelin levels are associated with higher
insulin-mediated glucose disposal in non-diabetic maintenance
hemodialysis patients. Clin Nutr. 27:142–149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kobayashi S, Oka M, Maesato K, Ikee R,
Mano T, Hidekazu M and Ohtake T: Coronary artery calcification,
ADMA, and insulin resistance in CKD patients. Clin J Am Soc
Nephrol. 3:1289–1295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Parfrey PS, Foley RN, Harnett JD, Kent GM,
Murray D and Barre PE: Outcome and risk factors of ischemic heart
disease in chronic uremia. Kidney Int. 49:1428–1434. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Mitsnefes MM: Cardiovascular complications
of pediatric chronic kidney disease. Pediatr Nephrol. 23:27–39.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Feldt-Rasmussen B, Lange M, Sulowicz W,
Gafter U, Lai KN, Wiedemann J, Christiansen JS and El Nahas M: APCD
Study Group: Growth hormone treatment during hemodialysis in a
randomized trial improves nutrition, quality of life and
cardiovascular risk. J Am Soc Nephrol. 18:2161–2171. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Chang CC, Hung CH, Yen CS, Hwang KL and
Lin CY: The relationship of plasma ghrelin level to energy
regulation, feeding and left ventricular function in non-diabetic
haemodialysis patients. Nephrol Dial Transplant. 20:2172–2177.
2005. View Article : Google Scholar : PubMed/NCBI
|
